Emerging roles of ferroptosis in cardiovascular diseases

被引:0
|
作者
Kai Wang
Xin-Zhe Chen
Yun-Hong Wang
Xue-Li Cheng
Yan Zhao
Lu-Yu Zhou
Kun Wang
机构
[1] Qingdao University,Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine
[2] Peking Union Medical College,State Key Laboratory of Cardiovascular Disease, Heart Failure center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences
[3] Shandong Provincial Maternal and Child Health Care Hospital affiliated to Qingdao University,Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The mechanism of cardiovascular diseases (CVDs) is complex and threatens human health. Cardiomyocyte death is an important participant in the pathophysiological basis of CVDs. Ferroptosis is a new type of iron-dependent programmed cell death caused by excessive accumulation of iron-dependent lipid peroxides and reactive oxygen species (ROS) and abnormal iron metabolism. Ferroptosis differs from other known cell death pathways, such as apoptosis, necrosis, necroptosis, autophagy and pyroptosis. Several compounds have been shown to induce or inhibit ferroptosis by regulating related key factors or signalling pathways. Recent studies have confirmed that ferroptosis is associated with the development of diverse CVDs and may be a potential therapeutic drug target for CVDs. In this review, we summarize the characteristics and related mechanisms of ferroptosis and focus on its role in CVDs, with the goal of inspiring novel treatment strategies.
引用
收藏
相关论文
共 50 条
  • [41] Ferroptosis in cardiovascular diseases: role and mechanism
    Zhang, Qi
    Luo, Yuhao
    Peng, Lin
    Rong, Xi
    Liu, Yingxue
    Li, Jiafu
    Luo, Jing
    CELL AND BIOSCIENCE, 2023, 13 (01):
  • [42] Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches
    Zhou, Xianpeng
    Wang, Hao
    Yan, Biao
    Nie, Xinwen
    Chen, Qingjie
    Yang, Xiaosong
    Lei, Min
    Guo, Xiying
    Ouyang, Changhan
    Ren, Zhanhong
    CARDIOVASCULAR DRUGS AND THERAPY, 2024,
  • [43] Cardiac α1A-adrenergic receptors: emerging protective roles in cardiovascular diseases
    Zhang, Jiandong
    Simpson, Paul C.
    Jensen, Brian C.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2021, 320 (02): : H725 - H733
  • [44] New and emerging roles of small RNAs in neurodegeneration, muscle, cardiovascular and inflammatory diseases
    Hruska-Plochan, Marian
    Li, Bei
    Kyburz, Diego
    Kruetzfeldt, Jan
    Landmesser, Ulf
    Aguzzi, Adriano
    Polymenidou, Magdalini
    SWISS MEDICAL WEEKLY, 2015, 145
  • [45] Emerging regulatory mechanisms in cardiovascular disease: Ferroptosis
    Jin, Sijie
    Wang, He
    Zhang, Xiaohao
    Song, Mengyang
    Liu, Bin
    Sun, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [46] Ferroptosis as an emerging therapeutic target in liver diseases
    Lu, Yuzhen
    Hu, Junjie
    Chen, Liang
    Li, Shan
    Yuan, Ming
    Tian, Xianxiang
    Cao, Peng
    Qiu, Zhenpeng
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [47] Emerging Pathological Engagement of Ferroptosis in Gut Diseases
    Gao, Weihua
    Zhang, Ting
    Wu, Hao
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
  • [48] The emerging roles of ferroptosis in cells of the central nervous system
    Li, Yuyao
    Xiao, Dongqiong
    Wang, Xiaodong
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [49] MiRNA Regulates Ferroptosis in Cardiovascular and Cerebrovascular Diseases
    Liu, Yiman
    Yang, Peijuan
    Wang, Jingjing
    Peng, Wu
    Zhao, Jinli
    Wang, Zuo
    DNA AND CELL BIOLOGY, 2024, 43 (10) : 492 - 509
  • [50] The Regulation of Pyroptosis and Ferroptosis by MicroRNAs in Cardiovascular Diseases
    Shariati, Akram
    Raberi, Venus Shahabi
    Masumi, Mehdi
    Tarbiat, Ali
    Rastgoo, Elham
    Zadeh, Reza Faramarz
    GALEN MEDICAL JOURNAL, 2023, 12